(Q30392305)

English

Recombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A(H1N1) influenza virus infection in ferrets

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Recombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A(H1N1) influenza virus infection in ferrets (English)

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

0 references

9

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

object named as

Rogier Bodewes

2

0 references

Peter J M Rottier

10

object named as

Peter J M Rottier

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Berend Jan Bosch

1

object named as

Berend Jan Bosch

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Guus Rimmelzwaan

7

object named as

Guus F Rimmelzwaan

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Geert van Amerongen

6

object named as

Geert van Amerongen

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Robert P. de Vries

3

object named as

Robert P de Vries

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Cornelis A. M. de Haan

8

object named as

Cornelis A M de Haan

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Joost H C M Kreijtz

4

object named as

Joost H C M Kreijtz

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

author name string

Willem Bartelink

5

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

publication date

4 August 2010

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Journal of Virology

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

84

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

19

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

10366-10374

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

A single immunization with soluble recombinant trimeric hemagglutinin protects chickens against highly pathogenic avian influenza virus H5N1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937797

20 June 2018

The influenza A virus hemagglutinin glycosylation state affects receptor-binding specificity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937797

20 June 2018

Severity of pneumonia due to new H1N1 influenza virus in ferrets is intermediate between that due to seasonal H1N1 virus and highly pathogenic avian influenza H5N1 virus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937797

20 June 2018

Expression systems for therapeutic glycoprotein production.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937797

20 June 2018

Glycans on influenza hemagglutinin affect receptor binding and immune response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937797

20 June 2018

Intramuscular Matrix-M-adjuvanted virosomal H5N1 vaccine induces high frequencies of multifunctional Th1 CD4+ cells and strong antibody responses in mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937797

20 June 2018

Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937797

20 June 2018

Extrapolating from sequence--the 2009 H1N1 'swine' influenza virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937797

20 June 2018

Progress on baculovirus-derived influenza vaccines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937797

20 June 2018

Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937797

20 June 2018

Changing perspective on immunization against influenza

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937797

20 June 2018

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937797

20 June 2018

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937797

20 June 2018

Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937797

20 June 2018

Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937797

20 June 2018

Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937797

20 June 2018

Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937797

20 June 2018

Dissociation of influenza virus hemagglutinin and neuraminidase eliminates their intravirionic antigenic competition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937797

20 June 2018

A switch between two-, three-, and four-stranded coiled coils in GCN4 leucine zipper mutants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937797

20 June 2018

Further studies of the neuraminidase content of inactivated influenza vaccines and the neuraminidase antibody responses after vaccination of immunologically primed and unprimed populations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937797

20 June 2018

Microneutralization test for influenza A and B and parainfluenza 1 and 2 viruses that uses continuous cell lines and fresh serum enhancement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937797

20 June 2018

Protective Effects of Specific Immunity to Viral Neuraminidase on Influenza Virus Infection of Mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937797

20 June 2018

Antiviral Activity of Antiserum Specific for an Influenza Virus Neuraminidase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937797

20 June 2018

Antigen-presenting B cells and helper T cells cooperatively mediate intravirionic antigenic competition between influenza A virus surface glycoproteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937797

20 June 2018

Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937797

20 June 2018

Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase glycoproteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937797

20 June 2018

Seasonal influenza vaccine provides priming for A/H1N1 immunization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937797

26 November 2018

Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937797

26 November 2018

Protection of mice with recombinant influenza virus neuraminidase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937797

26 November 2018

Supplementation of conventional trivalent influenza vaccine with purified viral N1 and N2 neuraminidases induces a balanced immune response without antigenic competition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937797

26 November 2018

Antigenic and molecular heterogeneity in recent swine influenza A(H1N1) virus isolates with possible implications for vaccination policy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937797

26 November 2018

Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937797

26 November 2018

Recombinant neuraminidase vaccine protects against lethal influenza.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937797

26 November 2018

Infection-permissive immunization with influenza virus neuraminidase prevents weight loss in infected mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937797

26 November 2018

Influenza A virus vaccines containing purified recombinant H3 hemagglutinin are well tolerated and induce protective immune responses in healthy adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937797

26 November 2018

Reactions of antibodies with surface antigens of influenza virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2937797

26 November 2018

Divergent evolution of hemagglutinin and neuraminidase genes in recent influenza A:H3N2 viruses isolated in Canada

1 reference

https://pubmed.ncbi.nlm.nih.gov/20686020

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An enzyme-linked lectin assay for sialidase

1 reference

https://pubmed.ncbi.nlm.nih.gov/20686020

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant baculovirus influenza A hemagglutinin vaccines are well tolerated and immunogenic in healthy adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/20686020

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FluBlok, a recombinant influenza vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/20686020

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influenza neuraminidase as a vaccine antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/20686020

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/JVI.01035-10

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30392305&oldid=1968921446"